Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
76.47
-0.66 (-0.86%)
Aug 3, 2026, 4:00 PM EDT - Market closed
Cytokinetics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Reiterates $146 | Buy | Reiterates | $146 | +90.92% | Jul 31, 2026 |
| Needham | Needham | Buy Maintains $102 | Buy | Maintains | $102 | +33.39% | Jul 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $140 | Buy | Reiterates | $140 | +83.08% | Jul 30, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $103 | Buy | Reiterates | $103 | +34.69% | Jul 23, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $83 | Hold | Maintains | $83 | +8.54% | Jul 22, 2026 |
| Citi | Citi | Buy Maintains $99 | Buy | Maintains | $99 | +29.46% | Jul 16, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $119 → $117 | Buy | Maintains | $119 → $117 | +53.00% | Jul 7, 2026 |
| UBS | UBS | Buy Upgrades $115 | Buy | Upgrades | $115 | +50.39% | Jun 29, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.